Vardenafil (Levitra/Staxyn) Cost in Nevada 2026

At a glance
- Brand price (Levitra) / ~$350/month cash pay in Nevada
- Generic vardenafil cash price / ~$120/month at Nevada retail pharmacies (2026)
- Compounded vardenafil (503A) / Available; cost varies by pharmacy, often significantly lower than retail
- Nevada Medicaid coverage / Not covered for erectile dysfunction
- Telehealth prescribing / Permitted in Nevada
- Dose form / Oral tablet (vardenafil) or orally disintegrating tablet (Staxyn 10 mg)
- Typical dosing / On-demand, 30 to 60 minutes before sexual activity
- FDA approval / Levitra approved August 2003; Staxyn approved June 2010
- Manufacturer savings card (Bayer) / May reduce out-of-pocket cost for commercially insured patients
- Generic availability / Yes; multiple manufacturers
What Does Vardenafil Actually Cost in Nevada?
Generic vardenafil tablets run about $120 per month at Nevada retail pharmacies on a cash-pay basis in 2026. Brand-name Levitra carries a manufacturer list price near $350 per month. Staxyn (the orally disintegrating 10 mg formulation) is priced similarly to brand Levitra and has no generic equivalent.
Brand vs. Generic Price Gap
The gap between brand and generic is large. Bayer's Levitra lost U.S. Patent exclusivity, which allowed multiple generic manufacturers to enter the market and drive retail prices down sharply. At GoodRx-negotiated rates, some Nevada pharmacies dispense 30 tablets of generic vardenafil 10 mg for under $90. Prices vary by pharmacy, zip code, and whether you use a discount card.
Staxyn vs. Levitra vs. Generic Tablet
Staxyn is the orally disintegrating tablet form. It dissolves on the tongue without water, which some patients prefer. Because Staxyn has no generic, its cash price stays close to brand Levitra. If cost is the deciding factor, the standard generic tablet is the least expensive brand-equivalent option.
How Dosing Affects Monthly Cost
Vardenafil is taken on demand rather than daily. A patient using it four times per month pays far less than one using it eight times. Most prescriptions are written for 30 tablets but patients routinely use fewer. The FDA-approved dose range is 5 mg, 10 mg, and 20 mg; the 20 mg tablet often costs only marginally more per pill than the 10 mg tablet, so dose-splitting under physician guidance can reduce monthly spend further [1].
Nevada Medicaid and Vardenafil Coverage
Nevada Medicaid does not cover vardenafil or any PDE5 inhibitor prescribed for erectile dysfunction. This exclusion is consistent with federal guidance: the Deficit Reduction Act of 2005 prohibited federal Medicaid funds from covering drugs prescribed solely for sexual dysfunction [2]. Nevada has not elected to fill that gap with state funds.
What Nevada Medicaid Does Cover
Nevada Medicaid covers PDE5 inhibitors when prescribed for an FDA-approved non-sexual-dysfunction indication, specifically pulmonary arterial hypertension (PAH). Sildenafil (Revatio) and tadalafil (Adcirca) hold FDA approval for PAH; vardenafil does not. A Nevada Medicaid beneficiary prescribed vardenafil for erectile dysfunction will pay full cost out of pocket.
Nevada Check Up and CHIP
Nevada Check Up (the state CHIP program) mirrors Medicaid's exclusion for sexual dysfunction medications. Patients in these programs should budget for full cash-pay pricing or pursue the savings strategies below.
Private Insurance Coverage for Vardenafil in Nevada
Most commercial plans in Nevada cover generic vardenafil only when the employer plan specifically opts in to an ED drug benefit. The Affordable Care Act does not require coverage of drugs prescribed for sexual dysfunction [3]. Many large Nevada employers exclude ED medications entirely.
Checking Your Nevada Plan
Call the member services number on your insurance card and ask: "Is vardenafil covered on your formulary, and if so, at what tier?" Plans that do cover it typically place generic vardenafil on Tier 2 or Tier 3, with copays ranging from $30 to $75 per 30-tablet fill after deductible. Brand Levitra, when covered, usually lands on Tier 4 or 5 (specialty or non-preferred brand), with cost shares that can exceed $150 per fill.
Prior Authorization Requirements
Some Nevada commercial plans require prior authorization for vardenafil even when it appears on the formulary. Prior authorization often requires documentation that the patient has tried and failed a step-therapy medication first, or that a diagnosis code consistent with ED is on file. Work with your prescribing clinician to submit documentation proactively.
Medicare Part D in Nevada
Medicare Part D plans are prohibited from covering drugs prescribed for erectile dysfunction by the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 [4]. No standard Part D plan in Nevada will cover vardenafil for ED, though formulary exclusions do not apply to medically necessary off-label uses reviewed case by case.
Is Compounded Vardenafil Legal in Nevada?
Yes. A Nevada-licensed 503A compounding pharmacy may legally prepare vardenafil compounds for individual patients when a valid prescription is presented. Section 503A of the Federal Food, Drug, and Cosmetic Act governs traditional compounding pharmacies and permits them to compound drugs that are not commercially available in the form or dose needed, provided they comply with state board of pharmacy regulations [5].
503A vs. 503B in Nevada
503B outsourcing facilities produce larger batches without a patient-specific prescription and are regulated more strictly by the FDA. Most compounded vardenafil dispensed to Nevada patients comes from 503A pharmacies. The Nevada State Board of Pharmacy licenses and inspects 503A facilities operating in-state; out-of-state 503A pharmacies shipping to Nevada patients must hold licensure in their home state and comply with Nevada shipping rules [6].
What Compounding Changes
A 503A pharmacy might prepare vardenafil in a different dose strength, a sublingual troche, or in combination with other compounds (for example, vardenafil plus oxytocin or PT-141). These preparations are not FDA-approved finished drug products and have not gone through the same clinical trial process as Levitra tablets. Patients should discuss the evidence base with their prescribing physician before choosing a compounded formulation over an FDA-approved generic.
Cost of Compounded Vardenafil in Nevada
Pricing is set by the individual pharmacy and is not standardized. Some telehealth platforms that dispense compounded vardenafil advertise costs well below retail generic pricing, sometimes including the clinical consultation fee. Because compounded drugs are not eligible for insurance reimbursement, all spending is out of pocket. Ask for an itemized cost breakdown including the pharmacy dispensing fee and shipping, where applicable.
Clinical Evidence Supporting Vardenafil
Vardenafil is a phosphodiesterase type 5 (PDE5) inhibitor. It works by blocking PDE5-mediated degradation of cyclic GMP in penile smooth muscle, prolonging smooth-muscle relaxation and facilitating erection in response to sexual stimulation [7].
Key Efficacy Data
Porst et al. (2003) conducted a randomized, double-blind, placebo-controlled trial across multiple countries assessing vardenafil 5 mg, 10 mg, and 20 mg in men with erectile dysfunction. The 20 mg dose produced successful intercourse in 75% of attempts vs. 52% for placebo (P<0.001) [8]. The International Index of Erectile Function (IIEF) erectile function domain score improved by 7.0 points on vardenafil 20 mg vs. 1.9 points on placebo.
FDA Approval Milestones
The FDA approved Levitra (vardenafil HCl) tablets in August 2003. Staxyn (vardenafil HCl) orally disintegrating tablets received approval in June 2010. The approved prescribing information establishes a starting dose of 10 mg taken approximately 60 minutes before sexual activity, adjustable to 5 mg or 20 mg based on efficacy and tolerability [1].
Safety Profile Relevant to Dosing Decisions
The most common adverse events in clinical trials were headache (15%), flushing (11%), and rhinitis (9%) at the 20 mg dose [8]. Vardenafil is contraindicated in patients taking nitrates in any form, because the combination can produce severe hypotension [1]. Patients on alpha-blockers require dose adjustment. Nevada clinicians should review the full prescribing information before initiating therapy.
Telehealth Prescribing of Vardenafil in Nevada
Nevada fully permits telehealth prescribing of vardenafil. State law (NRS 629.515) authorizes licensed Nevada practitioners to establish a valid patient-provider relationship via synchronous audio-visual telehealth and to prescribe Schedule V and non-scheduled legend drugs through that channel [9]. Vardenafil is not a controlled substance, so no additional DEA telemedicine registration is required beyond standard Nevada prescribing authority.
How a Nevada Telehealth Visit Works
A patient completes an intake form covering medical history, current medications, cardiovascular history, and ED history. The clinician reviews the intake, conducts a synchronous or asynchronous consultation, and, if appropriate, sends a prescription electronically to a pharmacy of the patient's choice. Some platforms send the prescription to an affiliated 503A compounding pharmacy; others allow patients to use GoodRx or a discount card at any local Nevada pharmacy.
Platforms That Serve Nevada
Several nationally operating telehealth platforms hold Nevada medical board registrations and serve patients in Las Vegas, Henderson, Reno, Sparks, and rural counties. Patients in rural Nevada counties with limited pharmacy access particularly benefit from mail-order dispensing paired with telehealth.
What to Bring to a Telehealth Visit
Prepare a list of all current medications, especially nitrates, alpha-blockers, antifungals (ketoconazole significantly increases vardenafil plasma levels), and HIV protease inhibitors [1]. Blood pressure readings from the past 30 days are useful. The clinician will screen for cardiovascular risk, because the Princeton Consensus Guidelines recommend risk stratification before initiating PDE5 inhibitor therapy [10].
Savings Strategies: Getting the Lowest Price in Nevada
GoodRx and Discount Cards
GoodRx, RxSaver, and similar platforms negotiate discounted rates at retail pharmacies. In Nevada, GoodRx prices for generic vardenafil 10 mg (30 tablets) range from approximately $55 to $130 depending on pharmacy location and current coupon rates. These cards are free to use and work at most major Nevada chains (Smith's Pharmacy, Walgreens, CVS, Walmart Pharmacy) and independent pharmacies.
Bayer Savings Card for Levitra
Bayer offers a savings card for commercially insured patients (not Medicaid or Medicare) that may reduce Levitra copay to as low as $0 for eligible fills. The card cannot be combined with federal or state insurance. Terms change periodically; check the official Bayer patient support page for current eligibility rules [11].
Splitting Higher-Dose Tablets
Under physician guidance, the 20 mg tablet may be split to approximate two 10 mg doses. The FDA prescribing information does not prohibit splitting, and the tablet is not film-coated in a way that alters pharmacokinetics when cut [1]. This approach effectively halves the per-dose cost of generic tablets.
90-Day Fills and Mail-Order Pharmacies
Requesting a 90-day supply through a mail-order pharmacy (OptumRx, Express Scripts, CVS Caremark) often reduces the per-tablet cost by 10% to 20% compared to monthly retail fills. This requires a prescription written for a 90-day supply and may require prior authorization from an insurance plan if covered.
Patient Assistance Programs
Bayer's patient assistance program may provide brand Levitra at no cost to uninsured or underinsured patients who meet income eligibility criteria. Income thresholds and application processes change annually. The NeedyMeds database (needymeds.org) maintains current program details for Nevada residents.
Comparing Vardenafil to Other PDE5 Inhibitors on Cost
Vardenafil competes with sildenafil (Viagra/generic), tadalafil (Cialis/generic), and avanafil (Stendra) in the Nevada market. Generic sildenafil is typically the least expensive PDE5 inhibitor available at Nevada pharmacies, with GoodRx prices sometimes under $1 per 100 mg tablet [12]. Generic tadalafil 5 mg (for daily use) runs approximately $30 to $60 per month at Nevada retail pharmacies.
When Vardenafil Is the Better Clinical Choice
Some patients experience fewer visual side effects with vardenafil than with sildenafil, because vardenafil is more selective for PDE5 over PDE6 (which mediates retinal phototransduction) [13]. Men on moderate alpha-blocker doses may tolerate vardenafil better than sildenafil at high doses, though the FDA label for both drugs requires caution with this combination [1]. Clinical choice should balance efficacy, tolerability, and cost in a shared decision-making conversation.
Avanafil vs. Vardenafil in Nevada
Avanafil (Stendra) has a faster onset, approximately 15 to 30 minutes in some patients, and no generic is available, making it the most expensive PDE5 inhibitor at Nevada cash prices, often exceeding $400 per month [14]. Patients who do not need the faster onset have little clinical reason to pay the premium.
Nevada-Specific Pharmacy Access and Logistics
Nevada has 17 counties. Clark County (Las Vegas) and Washoe County (Reno) account for the majority of the state's licensed pharmacies. Rural counties (Esmeralda, Mineral, Nye, and White Pine) have limited brick-and-mortar pharmacy presence, making mail-order and telehealth-paired dispensing particularly relevant for ED medication access.
Nevada Board of Pharmacy Licensure Verification
Before filling a compounded vardenafil prescription from an online pharmacy, Nevada patients should verify the dispensing pharmacy holds an active license through the Nevada State Board of Pharmacy (pharmacy.nv.gov). Unlicensed online pharmacies may dispense counterfeit or adulterated products [15].
Prescription Validity in Nevada
Nevada requires a valid patient-prescriber relationship before a prescription for vardenafil is issued. NRS 454.213 defines this relationship and prohibits prescriptions generated solely by an online questionnaire without clinical review. Reputable telehealth platforms conduct clinician review of every intake before issuing a prescription.
Frequently asked questions
›How much does vardenafil (Levitra/Staxyn) cost in Nevada?
›Does Nevada Medicaid cover vardenafil (Levitra/Staxyn)?
›Is compounded vardenafil legal in Nevada?
›Can I get vardenafil (Levitra/Staxyn) via telehealth in Nevada?
›Which insurance plans cover vardenafil (Levitra/Staxyn) in Nevada?
›What's the cheapest way to get vardenafil (Levitra/Staxyn) in Nevada?
›Are there Nevada vardenafil (Levitra/Staxyn) discount programs?
›How does the Bayer savings card work in Nevada?
References
- U.S. Food and Drug Administration. Levitra (vardenafil hydrochloride) tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/021400s020lbl.pdf
- Centers for Medicare and Medicaid Services. Deficit Reduction Act of 2005: Medicaid exclusion of drugs for erectile dysfunction. https://www.cms.gov/
- HealthCare.gov / CMS. Affordable Care Act essential health benefits: prescription drug coverage requirements. https://www.healthcare.gov/coverage/prescription-drugs/
- U.S. Food and Drug Administration. Medicare Prescription Drug, Improvement, and Modernization Act of 2003: Part D exclusions. https://www.fda.gov/
- U.S. Food and Drug Administration. Human drug compounding: 503A of the FD&C Act. https://www.fda.gov/drugs/human-drug-compounding/503a-outsourcing-facilities
- U.S. Food and Drug Administration. Compounding: guidance for 503A pharmacies. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
- Bischoff E. Potency, selectivity, and consequences of nonselectivity of PDE inhibition. Int J Impot Res. 2004;16(Suppl 1):S11-S14. https://pubmed.ncbi.nlm.nih.gov/15224129/
- Porst H, Rosen R, Padma-Nathan H, et al. The efficacy and tolerability of vardenafil, a new, oral, selective phosphodiesterase type 5 inhibitor, in patients with erectile dysfunction: the first at-home clinical trial. Int J Impot Res. 2003;15(2):117-123. https://pubmed.ncbi.nlm.nih.gov/12734428/
- Nevada Revised Statutes 629.515. Telehealth: provision of health care services. https://www.leg.state.nv.us/nrs/nrs-629.html
- Kostis JB, Jackson G, Rosen R, et al. Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference). Am J Cardiol. 2005;96(2):313-321. https://pubmed.ncbi.nlm.nih.gov/16018863/
- U.S. Food and Drug Administration. Staxyn (vardenafil hydrochloride) orally disintegrating tablets prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/022473lbl.pdf
- Hatzimouratidis K, Amar E, Eardley I, et al. Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation. Eur Urol. 2010;57(5):804-814. https://pubmed.ncbi.nlm.nih.gov/20189712/
- Corbin JD, Francis SH. Pharmacology of phosphodiesterase-5 inhibitors. Int J Clin Pract. 2002;56(6):453-459. https://pubmed.ncbi.nlm.nih.gov/12166545/
- Goldstein I, McCullough AR, Jones LA, et al. A randomized, double-blind, placebo-controlled evaluation of the safety and efficacy of avanafil in subjects with erectile dysfunction. J Sex Med. 2012;9(4):1122-1133. https://pubmed.ncbi.nlm.nih.gov/22248153/
- U.S. Food and Drug Administration. Buying medicines online: how to protect yourself. https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/beware-illegally-sold-medicines